FATE vs PGR · rev $13.6M vs P/E 10, rev $87.67B
Fate Therapeutics Inc (FATE) versus Progressive Corp (PGR) — a side-by-side from cached financials, not a winner call.
Fate Therapeutics Inc (FATE) is a biotechnology company listed on US.
Progressive Corp (PGR) is a insurance - property & casualty company listed on NYSE.
Latest reported FATE revenue for 2024-12-31 was $13.6M. Net income was -$186.3M. Revenue was down 78.5% from 2023-12-31 to 2024-12-31. FATE currently screens at market cap $331.0M.
Latest reported PGR revenue for 2025-12-31 was $87.67B. Net income was $11.31B. Revenue was up 16.3% from 2024-12-31 to 2025-12-31. PGR currently screens at market cap $119.28B and trailing P/E 10.4.
FATE currently screens at market cap $331.0M. PGR currently screens at market cap $119.28B and trailing P/E 10.4.
Not investment advice. Open the FATE and PGR stock pages for the full models.
Not investment advice.